Severe Hepatocellular Injury With Apoptosis Induced by a Hepatitis C Polymerase Inhibitor
- 1 April 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 43 (4) , 374-381
Abstract
Goals To describe the mechanisms of severe hepatocellular injury with apoptosis in 2 patients receiving hepatitis C virus (HCV)-796. Background HCV-796 is a hepatitis C polymerase inhibitor approved by the US Food and Drug Administration for a phase 2 study of the treatment of hepatitis C in combination with PEG-Interferon and ribavirin. Results The injury occurred after more than 12 weeks of treatment, with a >20-fold increase in serum alanine aminotransferase and aspartate aminotransferase, and a marked increase in total (and direct) bilirubin in the absence of cholestasis. There was no evidence of autoimmune or viral hepatitis. Involvement of the mitochondrial apoptotic pathway was demonstrated by (1) release of cytochrome C into the cytosol; (2) association of cytochrome C with apoptotic protease activating factor-1 in the cytosol; (3) activation of initiator caspase 9; (4) activation of effector caspase 3; (5) increased serum caspase-3 cleaved cytokeratin-18 peptide; (6) nuclear fragmentation; (7) mitochondrial structural abnormalities; (8) expression of light chain 3 B, an indicator of autophagy; (9) probable autophagy of mitochondria by autophagosomes; and (10) probable phagocytosis of apoptotic hepatocytes by activated macrophages. Immunoglobulin G immune complexes were identified in the hepatocytes and localized to the endoplasmic reticulum and Golgi of these patients after the drug-induced liver disease, reflecting a primary or secondary target. Hepatitis C treatment was discontinued at weeks 15 and 19 in patients 1 and 2, respectively. After more than 6 months off the medication, both patients normalized the serum alanine aminotransferase, aspartate aminotransferase, and total bilirubin with undetectable HCV RNA. Conclusions HCV-796 may cause severe hepatocellular injury and apoptosis, with a marked immune reaction in susceptible patients.Keywords
This publication has 39 references indexed in Scilit:
- A Ribosomal S-6 Kinase–Mediated Signal to C/EBP-β Is Critical for the Development of Liver FibrosisPLOS ONE, 2007
- Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissuesProceedings of the National Academy of Sciences, 2007
- GAPDH and Autophagy Preserve Survival after Apoptotic Cytochrome c Release in the Absence of Caspase ActivationCell, 2007
- Mechanisms of expression of apoptotic protease activating factor-1 (Apaf-1) in nuclear, mitochondrial and cytosolic fractions of the cerebral cortex of newborn pigletsNeuroscience Letters, 2007
- Idiosyncratic drug hepatotoxicityNature Reviews Drug Discovery, 2005
- Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosisJournal of Cell Biology, 2004
- Mechanisms of Troglitazone HepatotoxicityChemical Research in Toxicology, 2003
- LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processingThe EMBO Journal, 2000
- Concanavalin A-induced liver injury triggers hepatocyte proliferation.Journal of Clinical Investigation, 1998
- Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liverJournal of Hepatology, 1988